Aspire Biopharma Inc. (ASBP) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Aspire Biopharma Inc.

    NASDAQ: ASBP · Real-Time Price · USD
    0.56
    0.03 (5.11%)
    At close: Aug 28, 2025, 3:59 PM
    0.55
    -0.65%
    Pre-market: Aug 29, 2025, 09:05 AM EDT

    Aspire Biopharma Income Statement

    Financials in USD. Fiscal year is undefined.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023
    Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023
    Revenue
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Cost of Revenue
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Gross Profit
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Operating Income
    		 -17.24M -16.54M -1.14M -579.72K -402.63K -395.98K -232.11K -155.81K -90.27K
    Interest Income
    		 625.42K 795.33K 548.68K 260.67K 439.41K 269.49K 516.15K 255.48K n/a
    Pretax Income
    		 -18.9M -17.02M -1.24M -579.72K -402.63K -395.98K -232.11K -155.81K -90.27K
    Net Income
    		 -30.13M -28.25M -12.47M -581.21K -403.12K -396.46K -232.59K -155.81K -90.27K
    Selling & General & Admin
    		 18.52M 18.16M 3.09M 608.31K 423.46K 416.81K 196.34K 130.53K 79.77K
    Research & Development
    		 739.34K 396.95K 144.36K 38.5K 46.27K 46.27K 35.77K 25.27K 10.5K
    Other Expenses
    		 -77.41K -77.41K -144.51K -67.1K -67.1K -67.1K n/a n/a n/a
    Operating Expenses
    		 19.18M 18.48M 3.09M 579.72K 402.63K 395.98K 232.11K 155.81K 90.27K
    Interest Expense
    		 1.72M 1.4M 1.29M 408.96K 400.46K 192.28K 8.97K n/a n/a
    Selling & Marketing Expenses
    		 183.48K 137.17K 5K 137.99K 121.31K 127.31K 39.64K 11K 11K
    Cost & Expenses
    		 19.18M 18.48M 3.09M 579.72K 402.63K 395.98K 232.11K 155.81K 90.27K
    Income Tax Expense
    		 n/a n/a n/a 1.49K 481.00 481.00 481.00 n/a n/a
    Shares Outstanding (Basic)
    		 49.33M 7.77M 7.77M 45.94M 45.94M 45.94M 45.94M 45.94M 45.94M
    Shares Outstanding (Diluted)
    		 49.33M 7.77M 7.77M 45.94M 45.94M 45.94M 45.94M 45.94M 45.94M
    EPS (Basic)
    		 -3.25 -3.21 -1.16 -0.01 -0.01 -0.01 -0.01 -0.00 -0.00
    EPS (Diluted)
    		 -3.25 -3.21 -1.16 -0.01 -0.01 -0.01 -0.01 -0.00 -0.00
    EBITDA
    		 -25.99M -24.63M -8.98M -415.84K -238.76K -232.11K -232.11K -155.81K -90.27K
    EBIT
    		 -28.42M -27.07M -11.58M -579.72K -402.63K -395.98K -232.11K -155.81K -90.27K
    Depreciation & Amortization
    		 2.44M 2.44M 2.6M 163.87K 163.87K 163.87K n/a n/a n/a

    Add to Watchlist